Cover Image

Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment

Background/Aim There has been a long-standing debate about the association of directacting antiviral (DAA) therapy and hepatocellular carcinoma (HCC) recurrence. This study aimed to investigate the association between DAA therapy and HCC recurrence after curative therapy. Methods We retrospectively...

Full description

Saved in:

Bibliographic Details
Main Authors:	Young-Hwan Ahn (Author), Heirim Lee (Author), Ji Eun Han (Author), Hyo Jung Cho (Author), Jae Youn Cheong (Author), Bumhee Park (Author), Soon Sun Kim (Author)
Format:	Book
Published:	Korean Liver Cancer Association, 2022-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report
by: Ji Eun Han, et al.
Published: (2021)

Is direct-acting antiviral treatment beneficial or harmful for patients with hepatitis C virus-related hepatocellular carcinoma?
by: Hye Won Lee
Published: (2022)

Virus infection and direct-acting antivirals in pregnancy
by: Xuan Huang, et al.
Published: (2022)

Direct Acting Antiviral Drugs: Pharmacokinetics and Drug-Drug Interactions
by: Marina Barakat, et al.
Published: (2022)

Heavy smoking increases early mortality risk in patients with hepatocellular carcinoma after curative treatment
by: Jaejun Lee, et al.
Published: (2024)

IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
by: Yadong Wang, et al.
Published: (2022)

Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals
by: Andrew Hill, et al.
Published: (2018)

P20 Monitoring the uptake of hepatitis C: direct acting antiviral treatment in Australia
by: B. Hajarizadeh, et al.
Published: (2017)

Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
by: Leah L. Zullig, et al.
Published: (2019)

The effect of cognitive emotion regulation on direct-acting antivirals adherence in patients with hepatitis C
by: Adina Turcu-Stiolica, et al.
Published: (2024)

Strategies for treating and managing chronic hepatitis C in children in the direct-acting antiviral era
by: Suk-Jin Hong, et al.
Published: (2020)

Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era
by: Sanam Hariri, et al.
Published: (2020)

Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances
by: Chiara Tammaro, et al.
Published: (2023)

Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals
by: Trinks J, et al.
Published: (2017)

Retrospective Evaluation on Patient Screening and Counseling Service on Direct-acting Antivirals Against Hepatitis C
by: Bob Ka Him Wong, et al.
Published: (2020)

Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
by: Mohamed M Sakr, et al.
Published: (2019)

Direct-acting antivirals for chronic Hepatitis C are effective and safe: an observational study in Londrina/PR
by: Hodnei Takashi Machado, et al.
Published: (2022)

Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
by: Stelliana Goutzamanis, et al.
Published: (2021)

Hepatitis C: sociodemographic and clinical profile of patients treated with direct-acting antivirals in a pharmaceutical office
by: Karem Aline Pegoraro, et al.
Published: (2023)

Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases
by: Nicola Imperatore, et al.
Published: (2017)

Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals
by: Saima Mushtaq, et al.
Published: (2022)

Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy
by: Nadia A. Nabulsi, et al.
Published: (2020)

Patients' preferences for treatment with the new direct acting antiviral therapies for chronic hepatitis C virus infection
by: MA Simón, et al.
Published: (2021)

Immunological Dynamics Associated with Direct-Acting Antiviral Therapies in Naive and Experimented HCV Chronic-Infected Patients
by: Grenda Leite Pereira, et al.
Published: (2019)

Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort
by: Bernuth S, et al.
Published: (2017)

Curative liver transplantation after lung resection for advanced hepatocellular carcinoma with lung metastasis and inferior vena cava tumor thrombosis: a case report
by: Dong Jin Joo, et al.
Published: (2021)

Autoimmune hepatitis associated Hepatitis C virus infection treated with fi rst generation direct-acting antivirals
by: Juan Diego Castro Limo, et al.
Published: (2019)

Uptake of hepatitis C direct-acting antiviral treatment in China: a retrospective study from 2017 to 2021
by: Xinyu Du, et al.
Published: (2023)

Barriers to access to hepatitis C treatment with direct-acting antivirals in people who inject drugs in the community setting
by: Elena Yela, et al.
Published: (2024)

Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
by: Tony Antoniou, et al.
Published: (2023)

Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017-2021
by: Anthony Martinez, et al.
Published: (2023)

Interventions to Improve Uptake of Direct-Acting Antivirals for Hepatitis C Virus in Priority Populations: A Systematic Review
by: David Ortiz-Paredes, et al.
Published: (2022)

O10 Treatment of Aboriginal and Torres Strait Islander clients with direct acting antivirals at the Kirketon Road Centre
by: R. Gilliver, et al.
Published: (2017)

Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries
by: Melissa J. Barber, et al.
Published: (2020)

Evaluation of the effect of direct-acting antiviral agents on melatonin level and lipid peroxidation in chronic hepatitis C patients
by: Nageh Ahmed El-Mahdy, et al.
Published: (2023)

High sustained virological response rates using imported generic direct acting antiviral treatment for hepatitis C
by: Andrew Hill, et al.
Published: (2017)

Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
by: Ramy H. Agwa, et al.
Published: (2022)

Impact of drug use policy on the appropriate use of direct acting antiviral agents for Hepatitis C in Saudi Arabia
by: Ahmed Saqer Alotaibi, et al.
Published: (2021)

Role of different direct-acting antiviral drugs on hepatitis C virus-associated mixed cryoglobulinemia in Egyptian patients
by: Tarek A Elshazly, et al.
Published: (2019)

Antiviral therapy for recurrent genital herpes
by: P R Abakarova, et al.
Published: (2014)